Hepatitis C virus-like particles induce virus-specific humoral and cellular immune responses in mice

Hepatology

Volumn 34, Issue 2, 2001, Pages 417-423

  Lechmann, M ^a   Murata, K ^a   Satoi, J ^a   Vergalla, J ^a   Baumert, T F ^a   Liang, T J ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA [N (N',N' DIMETHYLAMINOETHANE)CARBAMOYL]CHOLESTEROL; GAMMA INTERFERON; LIPID; OLIGONUCLEOTIDE; POLYPROTEIN; PROTEIN P7; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; HEPATITIS C VIRUS; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; VIRION; VIRUS PARTICLE;

EID: 0034915714     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.26523     Document Type: Article

References (46)

1. Pathogenesis, natural history, treatment, and prevention of hepatitis C
2. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: Potential role in chronic HCV infections
3. Vaccination of chimpanzees against infection by the hepatitis C virus
4. Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection
5. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C
6. Analysis of a successful immune response against hepatitis C virus
7. Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: Implications for vaccine development
8. Strategies and prospects for vaccination against the hepatitis C viruses
9. Vaccine development for hepatitis C
10. Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: Evidence for homologous and partial heterologous protection
11. Recombinant rabbit hemorrhagic disease virus capsid protein expressed in baculovirus self-assembles into viruslike particles and induces protection
12. Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus
13. Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: Implications on HIV vaccine development
14. Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice
15. Induction of HPV16 capsid protein-specific human T cell responses by virus-like particles
16. Hepatitis C virus structural proteins assemble into viruslike particles in insect cells
17. Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate
18. Plasmid DNA-based immunization for hepatitis C virus structural proteins: Immune responses in mice
19. Use of the human elongation factor 1 alpha promoter as a versatile and efficient expression system
20. Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C
21. CpG-containing oligonucleotides are efficient adjuvants for induction of protective anti-viral immune responses with T-cell peptide vaccines
22. Cationic lipid DC-Chol induces an improved and balanced immunity able to overcome the unresponsiveness to the hepatitis B vaccine
23. Dengue virus premembrane and membrane proteins elicit a protective immune response
24. Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection
25. Hepatitis C virus glycoprotein complex localization in the endoplasmic reticulum involves a determinant for retention and not retrieval
26. Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein
27. Characterization of modified hepatitis C virus E2 proteins expressed on the cell surface
28. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells
29. T-lymphocyte response to hepatitis C virus in different clinical courses of infection
30. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections
31. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response
32. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus - Positive blood donors without viremia
33. Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia
34. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection
35. CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes
36. Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C
37. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C
38. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection
39. Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection
40. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C
41. Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic lymphocyte responses in vivo
42. Induction of V3-specific cytotoxic T lymphocyte responses by HIV gag particles carrying multiple immunodominant V3 epitopes of gp120
43. Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model
44. Cytotoxic T cells and neutralizing antibodies induced in rhesus monkeys by virus-like particle HIV vaccines in the absence of protection from SHIV infection
45. Hepatitis B virus immunopathogenesis
46. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions